News & Events

With their eclectic mix of mutations, tumors often survive drug treatment. In a new study, researchers found a way to use cancer’s evolutionary potential against it, destroying drug-resistant tumors in animals.

NIBIB has designed an initiative called Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (eBEITA) at HBCUs. Recently, NIBIB made its first round of eBEITA grants to two HBCUs.

NIH has announced winners of the RADx® Tech Fetal Monitoring Challenge, a $2 million prize competition to speed development of innovative medical technologies for fetal health diagnosis, detection and monitoring.

Researchers are developing preclinical microgrippers that could be deployed throughout the upper urinary tract to grab tiny pieces of tissue and facilitate early detection of disease.